{"transactions":[{"id":712240,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-09T23:22:41.000Z","date":"2026-07-09","kind":"sale","planned":false,"acquired":false,"shares":67971,"price":6.9637,"value":473329.6527,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1306108,"source":{"system":"sec-edgar","filing":"0001493152-26-032744","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226032744/ownership.xml","form_type":"4"}},{"id":745553,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:52.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":31916,"price":5.3042,"value":169288.8472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1374079,"source":{"system":"sec-edgar","filing":"0001493152-26-028020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028020/ownership.xml","form_type":"4"}},{"id":745552,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:52.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":24428,"price":5.4295,"value":132631.826,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1405995,"source":{"system":"sec-edgar","filing":"0001493152-26-028020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028020/ownership.xml","form_type":"4"}},{"id":824811,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T01:03:36.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":29985,"price":4.3849,"value":131481.2265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.31 to $4.43 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1430423,"source":{"system":"sec-edgar","filing":"0001493152-26-014418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226014418/ownership.xml","form_type":"4"}},{"id":933853,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-23T01:33:56.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":69832,"price":5.3309,"value":372267.4088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1460408,"source":{"system":"sec-edgar","filing":"0001493152-26-003283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003283/ownership.xml","form_type":"4"}},{"id":936517,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:30:54.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":365422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029."}],"balance_after":1530240,"source":{"system":"sec-edgar","filing":"0001493152-26-002887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226002887/ownership.xml","form_type":"4"}},{"id":959059,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:30:11.000Z","date":"2025-12-29","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5.3096,"value":132740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of 25,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.215 to $5.41 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1164818,"source":{"system":"sec-edgar","filing":"0001493152-25-029384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225029384/ownership.xml","form_type":"4"}},{"id":1018030,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-16T20:15:06.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":249,"price":5.485,"value":1365.765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."}],"balance_after":1189818,"source":{"system":"sec-edgar","filing":"0001493152-25-018311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225018311/ownership.xml","form_type":"4"}},{"id":1030109,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-01T20:30:11.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5.2372,"value":130930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sale of 25,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.2725 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1190067,"source":{"system":"sec-edgar","filing":"0001493152-25-016543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225016543/ownership.xml","form_type":"4"}},{"id":1030108,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-01T20:30:11.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":19274,"price":5.3935,"value":103954.319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.46 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1215067,"source":{"system":"sec-edgar","filing":"0001493152-25-016543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225016543/ownership.xml","form_type":"4"}},{"id":1089821,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-10T20:30:38.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":69420,"price":5.8557,"value":406502.694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1234341,"source":{"system":"sec-edgar","filing":"0001641172-25-018606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018606/ownership.xml","form_type":"4"}},{"id":1120521,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-06T22:00:51.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":50676,"price":6.76,"value":342569.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.76 to $6.79 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1303761,"source":{"system":"sec-edgar","filing":"0001641172-25-014172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225014172/ownership.xml","form_type":"4"}},{"id":1126601,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:05:35.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":885,"price":6.24,"value":5522.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":1354437,"source":{"system":"sec-edgar","filing":"0001641172-25-013428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225013428/ownership.xml","form_type":"4"}},{"id":1188524,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-31T23:17:50.000Z","date":"2025-03-31","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":4.78,"value":119500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.81 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":1355322,"source":{"system":"sec-edgar","filing":"0001641172-25-001922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225001922/ownership.xml","form_type":"4"}},{"id":1297026,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-23T23:54:56.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":476435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 21, 2026, January 21, 2027 and January 21, 2028."}],"balance_after":1380322,"source":{"system":"sec-edgar","filing":"0001493152-25-003463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225003463/ownership.xml","form_type":"4"}},{"id":1385437,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-17T20:30:08.000Z","date":"2024-10-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":251,"price":6.54,"value":1641.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":903887,"source":{"system":"sec-edgar","filing":"0001493152-24-041421","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224041421/ownership.xml","form_type":"4"}},{"id":1398216,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-30T20:30:33.000Z","date":"2024-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":18798,"price":5.89,"value":110720.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":904138,"source":{"system":"sec-edgar","filing":"0001493152-24-038802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224038802/ownership.xml","form_type":"4"}},{"id":1458004,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-09T20:35:31.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":424000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of July 8, 2025, July 8, 2026 and July 8, 2027."}],"balance_after":922936,"source":{"system":"sec-edgar","filing":"0001493152-24-026642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026642/ownership.xml","form_type":"4"}},{"id":1487728,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-07T20:32:15.000Z","date":"2024-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":38621,"price":4.52,"value":174566.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":498936,"source":{"system":"sec-edgar","filing":"0001493152-24-023124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224023124/ownership.xml","form_type":"4"}},{"id":1491012,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-05T20:30:10.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":4.38,"value":3079.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":537557,"source":{"system":"sec-edgar","filing":"0001493152-24-022756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224022756/ownership.xml","form_type":"4"}},{"id":1534245,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-29T12:30:16.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.2,"value":32000.0,"ownership":{"direct":true},"balance_after":538260,"source":{"system":"sec-edgar","filing":"0001493152-24-016853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224016853/ownership.xml","form_type":"4"}},{"id":1656026,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-07T13:30:11.000Z","date":"2024-02-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.39,"value":87800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.34 to $4.40 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":528260,"source":{"system":"sec-edgar","filing":"0001493152-24-005208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224005208/ownership.xml","form_type":"4"}},{"id":1759515,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-17T20:30:29.000Z","date":"2023-10-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":181,"price":4.14,"value":749.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":508260,"source":{"system":"sec-edgar","filing":"0001493152-23-037500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223037500/ownership.xml","form_type":"4"}},{"id":1771883,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-29T21:25:15.000Z","date":"2023-09-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":13290,"price":3.93,"value":52229.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":508441,"source":{"system":"sec-edgar","filing":"0001493152-23-034916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034916/ownership.xml","form_type":"4"}},{"id":1771876,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-29T11:30:32.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.07,"value":81400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.88 to $4.19 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":521731,"source":{"system":"sec-edgar","filing":"0001493152-23-034741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034741/ownership.xml","form_type":"4"}},{"id":1864608,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-07T20:15:43.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":336826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026."}],"balance_after":501731,"source":{"system":"sec-edgar","filing":"0001493152-23-020417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223020417/ownership.xml","form_type":"4"}},{"id":1865747,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-06T20:15:21.000Z","date":"2023-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":827,"price":3.06,"value":2530.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":164905,"source":{"system":"sec-edgar","filing":"0001493152-23-020291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223020291/ownership.xml","form_type":"4"}},{"id":2135958,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-18T20:05:26.000Z","date":"2022-10-17","kind":"tax_withholding","acquired":false,"shares":207,"price":4.3,"value":890.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale."}],"balance_after":165732,"source":{"system":"sec-edgar","filing":"0001493152-22-028650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222028650/ownership.xml","form_type":"4"}},{"id":2149086,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-30T20:05:42.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":155200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026."}],"balance_after":165939,"source":{"system":"sec-edgar","filing":"0001493152-22-027279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027279/ownership.xml","form_type":"4"}},{"id":2229054,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-17T20:13:39.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":81525,"price":0.16,"value":13044.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale."}],"balance_after":268475,"source":{"system":"sec-edgar","filing":"0001493152-22-017159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222017159/ownership.xml","form_type":"4"}},{"id":2541092,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-18T20:05:17.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on October 15, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":0.91,"expiration_date":"2031-10-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-21-025690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025690/ownership.xml","form_type":"4"}},{"id":2541091,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-10-18T20:05:17.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of October 15, 2022, October 15, 2023, October 15, 2024 and October 15, 2025."}],"balance_after":350000,"source":{"system":"sec-edgar","filing":"0001493152-21-025690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025690/ownership.xml","form_type":"4"}},{"id":2684972,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Res./Clin. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T01:06:39.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest 25% on June 1, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":400000,"derivative":{"exercise_price":1.71,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001567619-21-011667","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000156761921011667/doc1.xml","form_type":"4"}},{"id":2684971,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Res./Clin. Dev."}}],"security":"Common stock","published_at":"2021-06-04T01:06:39.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock will vest 100% on each of June 1, 2022."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001567619-21-011667","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000156761921011667/doc1.xml","form_type":"4"}},{"id":2684970,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31327,"kind":"person","name":"Seshadri Vishwas","position":1,"cik":"0001865131","reported_name":"Seshadri Vishwas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Res./Clin. Dev."}}],"security":"Common stock","published_at":"2021-06-04T01:06:39.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of June 1, 2022, June 1, 2023, June 1, 2024 and June 1, 2025."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001567619-21-011667","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000156761921011667/doc1.xml","form_type":"4"}}]}